Empower Clinics - CEO, Steven McAuley.
CEO, Steven McAuley.
Source: Empower Clinics.
  • Empower’s (EPW) Medisure Laboratory signed a laboratory services agreement with Alp MedTech AG
  • Alp MedTech AG is the authorized representative of Atlas Medical Gmbh, a European specialist in in-vitro diagnostic tests and medical devices active in over 80 countries
  • Empower anticipates the agreement to generate new accretive revenue from clinical study services in the Dallas market
  • Empower is an integrated healthcare company providing body and mind wellness
  • Empower Clinics (EPW) is up by 16.67 per cent, trading at $0.035 per share

Empower’s (EPW) Medisure Laboratory signed a laboratory services agreement with Alp MedTech AG.

Alp MedTech AG is the authorized representative of Atlas Medical Gmbh, a European manufacturer and distributor of in-vitro diagnostic tests and medical devices with a presence in more than 80 countries.

Medisure Laboratory is a high-complexity lab providing diagnostic services and testing solutions.

Empower anticipates the agreement to generate new accretive revenue from clinical study services in the Dallas market. It will also complement Empower’s U.S. distribution with new medical devices and test products.

The agreement follows the companies’ previously announced partnership agreement and a separate laboratory services agreement with Specialist Network of North America.

“This is another accretive deal with a focus on the U.S. market,” stated Steven McAuley, Empower’s Chairman and CEO. “ALP clearly sees the value of Medisure Labs to help them perform the clinical studies in Dallas that are required for U.S. government FDA 510K approvals for the sale of Atlas equipment in the U.S. market.”

“With Dallas as a major healthcare hub in the U.S., Medisure Lab has the medical equipment, expertise and network of health professionals to help ALP and Atlas to enter the U.S. market efficiently and rapidly,” he added.

Empower is an integrated healthcare company providing body and mind wellness through clinics, digital and telemedicine care, medical devices and medical diagnostic laboratories.

Empower Clinics (EPW) is up by 16.67 per cent, trading at $0.035 per share as of 11:14 am EST.


More From The Market Online

Liberty Defense receives approval to deploy HEXWAVE in Canada

Liberty Defense (TSXV:SCAN) receives approval from the Innovation, Science and Economic Development Canada to deploy its HEXWAVE product.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

Xtract One partnership to secure entrances at major U.S. arena

Xtract One Technologies’ (TSX:XTRA) threat detection solution has been chosen as the first line of security at a multi-purpose indoor arena.
Critical Elements Lithium

Junior lithium stock unearths major discovery

Critical Elements Lithium (TSXV:CRE), a highly prospective junior lithium stock, details a major discovery on its Rose West property.